首页> 美国卫生研究院文献>Canadian Journal of Comparative Medicine >Validation of a disease model in Japanese quail (Coturnix coturnix japonica) with the use of Escherichia coli serogroup O2 isolated from a turkey
【2h】

Validation of a disease model in Japanese quail (Coturnix coturnix japonica) with the use of Escherichia coli serogroup O2 isolated from a turkey

机译:使用从火鸡中分离出的大肠杆菌血清群O2验证日本鹌鹑(Coturnix coturnix japonica)的疾病模型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study established a disease model and protocol for bacterial challenge with Escherichia coli serogroup O2 strain EC317 in Japanese quail. Five groups of 10 birds each were injected subcutaneously in the breast with 200 μL of a brain–heart infusion (BHI) culture containing 1 × 108, 1 × 107, 1 × 106, 1 × 105, or 1 × 104 colony-forming units/mL of the test organism, which had been isolated from a turkey with cellulitis and septicemia. Birds in a 6th group were controls that received sterile BHI alone. Localized lesions of cellulitis developed in all of the birds that received E. coli. The morbidity and mortality rates were highest (100%) in the birds receiving the highest dose of E. coli and decreased linearly with decreasing dose (P < 0.05). Severity of disease, including lesions of pericarditis and perihepatitis, was also directly proportional to the dose of E. coli. These findings indicate that this disease challenge protocol can be used to study disease resistance and immunologic consequences of contaminant exposure or other stressors in birds.
机译:这项研究建立了一种针对日本鹌鹑用大肠杆菌血清群O2菌株EC317进行细菌攻击的疾病模型和方案。五组,每组10只鸟,经皮下注射200μL含1×10 8 ,1×10 7 , 1×10 6 ,1×10 5 或1×10 4 集落形成单位/ mL受试生物分离自火鸡与蜂窝织炎和败血病。第六组的鸟类是仅接受无菌BHI的对照组。在所有接受大肠杆菌的禽类中都出现了蜂窝组织炎的局部病变。接受最高剂量大肠杆菌的鸡的发病率和死亡率最高(100%),并且随着剂量的降低呈线性下降(P <0.05)。疾病的严重程度,包括心包炎和肝炎的损害,也与大肠杆菌的剂量成正比。这些发现表明,该疾病挑战规程可用于研究禽类中污染物暴露或其他应激源的疾病抵抗力和免疫学后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号